Ganfeng dedicated conversion plant to take Goulamina spodumene concentrates, is currently under construction, will be ready early 2024.
Goulamina first spodumene concentrate is expected to be produced in May 2024 as Simon pointed out in December 2022; then fast expand to the Stage 2 for 831ktpa in December 2025. That's the fastest expansion plan in the industry. As the resource will be further updated in May 2023, it's very likely to see Goulamina resource size to grow to 180-200Mt, in my best guess, then Stage 3 expansion is not unlikely, imo.
- Forums
- ASX - By Stock
- General Discussion
Ganfeng dedicated conversion plant to take Goulamina spodumene...
-
- There are more pages in this discussion • 7,504 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LLL (ASX) to my watchlist
(20min delay)
|
|||||
Last
50.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $605.4M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
LLL (ASX) Chart |
Day chart unavailable
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online